Omeros | Spese Operative



Operating Expenses Cambiamento Data
Adma Biologics USD 80.47M 268K 2024-12
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Cytokinetics USD 157.21M 1.24M 2025-03
Dynavax Technologies USD 91.79M 18.13M 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
Insmed USD 340.96M 6.11M 2025-03
Knight Therapeutics CAD 89.06M 2.02M 2024-09
MacroGenics USD 35.94M 20.58M 2024-12
Pacira USD 166.93M 4.38M 2025-03
Pfizer USD 10.05B 8.12B 2025-03
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
United Therapeutics USD 411.6M 33.4M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Omeros Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.